Page last updated: 2024-08-24

repaglinide and Astrocytoma, Grade IV

repaglinide has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, RQ; Chen, XQ; Hu, DX; Xiao, ZX; Xie, XQ; Yu, SB1

Other Studies

1 other study(ies) available for repaglinide and Astrocytoma, Grade IV

ArticleYear
Identification of repaglinide as a therapeutic drug for glioblastoma multiforme.
    Biochemical and biophysical research communications, 2017, 06-17, Volume: 488, Issue:1

    Topics: Animals; Carbamates; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Glioblastoma; Humans; Mice; Mice, Inbred C57BL; Piperidines; Structure-Activity Relationship; Tumor Cells, Cultured

2017